Alexander Hardy became Genentech’s Chief Executive Officer March 1, 2019.Previously, he was head of Global Product Strategy, Roche Pharmaceuticals and served in a number of key leadership positions across Genentech and Roche for over 13 years.Alexander led cross-functional teams to develop and launch new medicines and indications in more than 100 countries worldwide. He also co-chaired Roche’s late-stage portfolio committee, with direct accountability for new formulations and devices, geographic expansion, and post-marketing investments.From 2014 to 2016, Alexander was head of Asia Pacific for Roche Pha...read more